Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
BUSINESS
LEO Pharma “Eager to Do More” after Astellas Deal to Expand Globally: CEO
Danish dermatology specialty firm LEO Pharma A/S will explore acquisition and collaboration opportunities to reach out to more patients in Japan and other markets even after it clinched its largest ever deal just last month to buy Astellas Pharma’s global…
To read the full story
Related Article
- Astellas Completes Transfer of Dermatology Biz to LEO Pharma
April 4, 2016
- Astellas to Transfer Global Dermatology Portfolio to LEO Pharma
November 12, 2015
BUSINESS
- Nipro Eyes 50-60 Stemirac Treatment Sites across Japan after Full Nod
November 20, 2026
- AstraZeneca’s Etcamah to Hit Japan Market on Nov. 27
November 20, 2026
- Japan Drug Makers’ Sales Seen Dipping in FY2026 on Co-Marketing Exits
November 20, 2026
- J&J’s Icotyde Could Broaden Psoriasis Treatment Options: Expert
November 20, 2026
- Nippon Kayaku to Acquire AstraZeneca’s Zoladex on Dec. 16
November 20, 2026





